Search alternatives:
recently reported » frequently reported (Expand Search), recently emerged (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
values decrease » values increased (Expand Search), largest decrease (Expand Search)
marked decrease » marked increase (Expand Search)
recently reported » frequently reported (Expand Search), recently emerged (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
values decrease » values increased (Expand Search), largest decrease (Expand Search)
marked decrease » marked increase (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Beta cell function derived from routine clinical measures reports and predicts treatment response to immunotherapy in recent-onset type 1 diabetes.
Published 2025“…</p><p><br></p><p dir="ltr">Research Designs and Method </p><p dir="ltr">Measures of beta cell function derived from clinical and biochemical measures were calculated using data from the BANDIT randomised trial of baricitinib in recent-onset type 1 diabetes. Measures that reported and predicted treatment efficacy were determined using linear regression and receiver-operator characteristic analysis respectively. …”
-
15
Video 1_The clinical application value of mixed reality in robotic laparoscopic partial nephrectomy.mp4
Published 2024“…All patients underwent mid-abdominal CT plain scans and enhancements. The MR group utilized three-dimensional reconstruction of CT data and employed 3D tablets and HoloLens glasses for preoperative discussions, surgical planning, and intraoperative guidance. …”
-
16
-
17
-
18
-
19
Characteristics of AEs reports.
Published 2025“…Various statistical techniques were applied in the analysis, such as the reporting odds ratio (ROR), proportional reporting ratio (PRR), multi-item gamma Poisson shrinker (MGPS), and Bayesian confidence propagation neural network (BCPNN), to evaluate the adverse events linked to toripalimab. …”
-
20